Search for: "Teva Pharmaceuticals"
Results 521 - 540
of 1,424
Sort by Relevance
|
Sort by Date
21 Sep 2015, 7:00 am
Just a few months after establishing this health and wellness cloud platform, IBM has secured its first Foundational Life Sciences partner for Watson Health in Teva Pharmaceutical Industries (NYSE:TEVA) of Petah Tikva, Israel. [read post]
17 Sep 2015, 4:59 pm
Teva Pharmaceuticals USA, Inc. v. [read post]
7 Sep 2015, 1:02 pm
Pointing to a number of shortcomings in patents in agriculture and pharmaceuticals, The Economist concludes that patents don’t. [read post]
7 Sep 2015, 10:01 am
The lawsuit named Purdue Pharma (maker of OxyContin), Teva Pharmaceutical Industries, Janssen Pharmaceuticals – a subsidiary of Johnson & Johnson, Endo Health Solutions, and Actavis, as well as affiliated companies.One reason why the lawsuit was filed is that Purdue, which makes the best-selling painkiller OxyContin, has never gone to trial on a case of OxyContin abuse. [read post]
1 Sep 2015, 9:59 pm
Patent No. 7,772,209, owned by Lilly, would be infringed by the ANDA products for which Defendants Teva Parenteral Medicines, Inc.; Teva Pharmaceuticals USA, Inc.; APP Pharmaceuticals, LLC; Barr Laboratories, Inc.; and Pliva Hrvatska D.O.O. sought approval to market (opinion).... [read post]
26 Aug 2015, 11:02 am
., Ltd. and licensed to Teva Pharmaceuticals Industries Ltd. [read post]
26 Aug 2015, 10:31 am
The defendant in this Hatch-Waxman case was a subsidiary of the generic drugmaker Teva Pharmaceutical Industries Ltd.link: http://www.washingtontimes.com/news/2015/aug/26/federal-court-backs-patent-protecting-eli-lilly-ca/ [read post]
3 Aug 2015, 4:01 pm
Remaining in the zone of patent law, PatLit carries a guest blog from the Wragge Lawrence Graham duo of Paul Inman and Andrew Maggs on inventive step and the role of the "obvious to try" test in Teva v Leo [Merpel posted on this very case yesterday, so now you have two commentaries to consider]. [read post]
3 Aug 2015, 5:10 am
In cross-examination, Teva's expert conceded that trying to find a solution for the incompatibility of the two active ingredients required a lot of work. [read post]
27 Jul 2015, 6:07 pm
By Miriam Swedlow Despite overruling the Federal Circuit’s prior practice of reviewing all aspects of patent claim construction de novo, the Supreme Court’s ruling in Teva Pharmaceuticals USA, Inc. v. [read post]
10 Jul 2015, 11:46 am
Cephalon, which is now owned by Teva, has agreed to pay the United States and participating states a total of $7.5 million. [read post]
10 Jul 2015, 6:00 am
In Teva Pharmaceuticals USA, Inc. v. [read post]
26 Jun 2015, 7:44 am
Law360.com provides insight into the background of the dispute in an article (subscription required for full access) that begins, "Drug purchasers challenging a no-authorized-generic settlement between GlaxoSmithKline PLC and Teva Pharmaceutical Industries ltd. told the Third Circuit on Friday that the U.S. [read post]
25 Jun 2015, 9:48 pm
Philips Electronics North America), the More They Stay the Same (Teva Pharmaceuticals USA, Inc. v. [read post]
24 Jun 2015, 9:59 pm
Teva Pharmaceuticals USA, Inc. [read post]
19 Jun 2015, 6:30 am
The agency approved generics from Alembic Pharmaceuticals, Hetero Labs, Teva Pharmaceuticals and Torrent Pharmaceuticals. [read post]
18 Jun 2015, 2:45 pm
**Of the commercial significance-->from http://www.marketwatch.com/story/momenta-pharmaceuticals-announces-cafc-decision-to-invalidate-remanded-teva-pharmaceuticals-patent-in-daily-copaxoner-20-mg-suit-2015-06-18? [read post]
16 Jun 2015, 6:00 am
Teva Pharmaceutical Industries, Ltd. will make a total of $1.2B available to compensate purchasers, including drug wholesalers, pharmacies, and insurers, who overpaid because of Cephalon’s illegal conduct. [read post]
4 Jun 2015, 8:00 am
Cephalon was subsequently acquired by Teva Pharmaceutical Industries Ltd. in 2011. [read post]
3 Jun 2015, 9:55 am
On May 28, the Federal Trade Commission (“FTC”) announced it had reached a $1.2 billion settlement with Teva Pharmaceuticals,[1] which acquired Cephalon in 2012, over reverse payment for its narcolepsy drug, Provigil. [read post]
